Mutations that cause aberrant activation of the Wnt Signaling Pathway are found in early stages of tumor development in colon carcinoma. The downstream components of the pathway are transcription factors that belong to the LEF/TCF family, and the focus of our lab is to study the regulation of the LEF1 gene. Northern blot analysis demonstrates that there are 3 LEF1 messages (3.6kb, 3.0kb, and 2.2kb) expressed from the locus. Two different promoters generate the 3.6 and 2.2 kb mRNA messages and have been characterized. The promoter for the 3.6kb message is a target of the Wnt pathway and is aberrantly expressed in colon cancer cell lines. The 3.0kb message is also aberrantly expressed in cancer, but its origin is not known. The focus of this proposal is to test the hypothesis that a region in exon 1 of the LEF1 gene harbors a third promoter which directs expression of the third LEF1 message (3.0kb) (Aim 1). Because the 3.6 and 3.0 kb messages are expressed together in colon cancer cell lines, we hypothesize that they are coordinately regulated. Due to the identification of a region in promoters 1 and 3 in exon 1 that contains putative Wnt and TGFbeta-response elements, experiments will be carried out to test if these elements individually play a role in the regulation of one or both promoters (Aim 2). If this putative regulatory region affects promoter activity, we plan to determine whether the Wnt and TGFbeta pathways cooperate to activate or act antagonistically to negatively regulate promoter 1 and 3 (Aim 3). Mutations in the TGFbeta Pathway are late events in the development of tumorigenesis, therefore, we hypothesize that the aberrant expression of LEF1 in colon carcinomas may be due to mutations that activate the Wnt pathway and mutations that inactivate the TGFbeta pathway.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
1F31GM067285-01
Application #
6584284
Study Section
Minority Programs Review Committee (MPRC)
Program Officer
Toliver, Adolphus
Project Start
2003-03-18
Project End
2005-08-31
Budget Start
2002-12-01
Budget End
2003-11-30
Support Year
1
Fiscal Year
2002
Total Cost
$25,486
Indirect Cost
Name
University of California Irvine
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Tsai, Becky Pinjou; Jimenez, Judith; Lim, Sharon et al. (2014) A novel Bcr-Abl-mTOR-eIF4A axis regulates IRES-mediated translation of LEF-1. Open Biol 4:140180
Jimenez, Judith; Jang, Gwendolyn M; Semler, Bert L et al. (2005) An internal ribosome entry site mediates translation of lymphoid enhancer factor-1. RNA 11:1385-99